AuranamideCAS# 740813-53-0 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products

Cas No. | 740813-53-0 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C32H30N2O4 | M.Wt | 506.6 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |

Auranamide Dilution Calculator

Auranamide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9739 mL | 9.8697 mL | 19.7394 mL | 39.4789 mL | 49.3486 mL |
5 mM | 0.3948 mL | 1.9739 mL | 3.9479 mL | 7.8958 mL | 9.8697 mL |
10 mM | 0.1974 mL | 0.987 mL | 1.9739 mL | 3.9479 mL | 4.9349 mL |
50 mM | 0.0395 mL | 0.1974 mL | 0.3948 mL | 0.7896 mL | 0.987 mL |
100 mM | 0.0197 mL | 0.0987 mL | 0.1974 mL | 0.3948 mL | 0.4935 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland

TsingHua University

The University of Michigan

Miami University

DRURY University

Jilin University

Fudan University

Wuhan University

Sun Yat-sen University

Universite de Paris

Deemed University

Auckland University

The University of Tokyo

Korea University
- Terrestriamide
Catalog No.:BCX2139
CAS No.:157536-49-7
- Quercetin-5-O-glucoside-3-O-rutinoside
Catalog No.:BCX2138
CAS No.:1478622-04-6
- Praeroside I
Catalog No.:BCX2137
CAS No.:121064-73-1
- Cryptostigmin II
Catalog No.:BCX2136
CAS No.:50906-57-5
- Davidigenin
Catalog No.:BCX2135
CAS No.:23130-26-9
- Pinocembrin 7-O-neohesperidoside
Catalog No.:BCX2134
CAS No.:13241-31-1
- Gerardianin A
Catalog No.:BCX2133
CAS No.:137171-31-4
- Euphopiloside A
Catalog No.:BCX2132
CAS No.:1610615-04-7
- Graciliflorin F
Catalog No.:BCX2131
CAS No.:1413941-67-9
- Eugenol 4-O-beta-D-(6'-O-galloyl) glucopyranoside
Catalog No.:BCX2130
CAS No.:152041-15-1
- Plumbagic acid
Catalog No.:BCX2129
CAS No.:75640-06-1
- Etuycomanol
Catalog No.:BCX2128
CAS No.:84633-28-3
- 5-Allyl-1-methoxy-2,3-dihydroxybenzene
Catalog No.:BCX2141
CAS No.:4055-72-5
- Notoginsenoside E
Catalog No.:BCX2142
CAS No.:193976-50-0
- Hydrastinine
Catalog No.:BCX2143
CAS No.:5936-29-8
- 15-O-Methylgraciliflorin F
Catalog No.:BCX2144
CAS No.:1411994-51-8
- 4-Hydroxy-2-methoxybenzoic acid
Catalog No.:BCX2145
CAS No.:90111-34-5
- Mangostanin
Catalog No.:BCX2146
CAS No.:463342-39-4
Anti-Inflammatory Effects of Auranamide and Patriscabratine-Mechanisms and In Silico Studies.[Pubmed:35956947]
Molecules. 2022 Aug 5;27(15):4992.
Auranamide and patriscabratine are amides from Melastoma malabathricum (L.) Smith. Their anti-inflammatory activity and nuclear factor erythroid 2-related factor 2 (NRF2) activation ability were evaluated using Escherichia coli lipopolysaccharide (LPSEc)-stimulated murine macrophages (RAW264.7) and murine hepatoma (Hepa-1c1c7) cells, respectively. The cytotoxicity of the compounds was assessed using a 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay. The anti-inflammatory activity was determined by measuring the nitric oxide (NO) production and pro-inflammatory cytokines (Interleukin (IL)-1beta, Interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha, and IL-6) and mediators (NF-kappaB and COX-2). NRF2 activation was determined by measuring the nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) quinone oxidoreductase 1 (NQO1), nuclear NRF2 and hemeoxygenase (HO)-1. In vitro metabolic stability was assessed using the mouse, rat, and human liver microsomes. The compounds were non-toxic to the cells at 10 muM. Both compounds showed dose-dependent effects in downregulating NO production and pro-inflammatory cytokines and mediators. The compounds also showed upregulation of NQO1 activity and nuclear NRF2 and HO-1 levels. The compounds were metabolically stable in mouse, rat and human liver microsomes. The possible molecular targets of NRF2 activation by these two compounds were predicted using molecular docking studies and it was found that the compounds might inhibit the Kelch domain of KEAP1 and GSK-3beta activity. The physicochemical and drug-like properties of the test compounds were predicted using Schrodinger small molecule drug discovery suite (v.2022-2).
LC-DAD-MS-based metabolite profiling of three species of Justicia (Acanthaceae).[Pubmed:23126522]
Nat Prod Res. 2013 Aug;27(15):1335-42.
Olean-12-en-3beta-24 diol (A), Auranamide (B), aurantiamide acetate (C), 2alpha,3beta-dihydroxy-olean-12-en-28-oic acid (D) and quindoline (E) were isolated from the dichloromethane (CH2Cl2) extract of the stems of Justicia secunda (Acanthaceae). Liquid chromatography with ultraviolet and mass spectrometric detection was used to acquire more knowledge of the chemical composition of this extract and to monitor variations in profiles of both the isolated and the other non-identified compounds in Justicia refractifolia and Justicia graciliflora. The compound classes, phenolic and olefinic amides, feruloyltyramine amides, 2,5-diaryl-3,4-dimethyltetrahydrofuranoid lignans, peptide alkaloids, phenylalanine derivatives, conjugated ynones, indolquinoline alkaloids, triterpenes and pigments, were tentatively identified based on the LC-DAD-APCI-MS analysis. The most frequently encountered compound among the species was Auranamide while the distribution of quindoline was limited to J. secunda. Moreover, the acetylcholinesterase inhibitory activity of the isolated compounds was determined.
Chemical constituents of the leaf of Alpinia mutica Roxb.[Pubmed:22946537]
Nat Prod Res. 2013;27(16):1468-70.
Hydrodistillation of the fresh leaves of Alpinia mutica afforded 0.005% colourless essential oil. GC and GC-MS analysis revealed the presence of 33 components accounting for 92.9% of the total oil, dominated by 20 sesquiterpenes (76.7%) and 10 monoterpenes (8.3%). The major constituent was found to be beta-sesquiphellandrene which was 29.2% of the total oil. Soxhlet extraction, followed by repeated column chromatography of the dried leaves yielded two phenolic compounds, identified as 5,6-dehydrokawain and aniba dimer A, together with one amide assigned as Auranamide. The structures of these compounds were determined by using spectroscopic analysis. Antibacterial screening of the essential oil, the crude and isolated compounds showed weak to moderate inhibitory activity.
Amides, triterpene and flavonoids from the leaves of Melastoma malabathricum L.[Pubmed:20582481]
J Nat Med. 2010 Oct;64(4):492-5.
Successive extraction of the dried leaves of Melastoma malabathricum, followed by purification using repeated chromatographic techniques, yielded six compounds, including two amides, Auranamide and patriscabratine, a triterpene, alpha-amyrin, and three flavonoids, quercitrin, quercetin and kaempferol-3-O-(2'',6''-di-O-p-trans-coumaroyl)-beta-glucoside. Their structures were elucidated by spectroscopic means and also by direct comparison of their spectroscopic data with respective published data. These three phenolic constituents were found to be active as free radical scavengers, with quercetin being the strongest radical scavenger, having an IC(50) value of 0.69 microM in the UV method. Quercitrin and kaempferol-3-O-(2'',6''-di-O-p-trans-coumaroyl)-beta-glucoside showed moderate radical scavenging, with IC(50) values of 74.1 and 108.8 microM, respectively.
Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis.[Pubmed:14993759]
Chem Pharm Bull (Tokyo). 2004 Mar;52(3):345-9.
Three new compounds: begonanline (1). nantoamide (2). and methyl (S)-glycerate (3). as well as forty-four known compounds have been isolated and characterized from the rhizomes of Begonia nantoensis. The structures of these compounds were determined by spectral analyses and/or X-ray crystallography. Among them, cucurbitacin B (4). dihydrocucurbitacin B (5). cucurbitacin E (6). dihydrocucurbitacin E (7). cucurbitacin I (8). and (-)-Auranamide (9). showed cytotoxicity against four human cancer cell lines. 3beta,22alpha-Dihydroxyolean-12-en-29-oic acid (10), indole-3-carboxylic acid (11), 5,7-dihydroxychromone (12), and (-)-catechin (13) demonstrated significant activity against HIV replication in H9 lymphocyte cells.